Härmark L - Search Results

1

Intensive monitoring of pregabalin: results from an observational, Web-based, prospective cohort study in the Netherlands using patients as a source of information.

Härmark L, van Puijenbroek E, Straus S, van Grootheest K. Härmark L, et al. Drug Saf. 2011 Mar 1;34(3):221-31. doi: 10.2165/11585030-000000000-00000. Drug Saf. 2011. PMID: 21332246

2

Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring.

Härmark L, van Hunsel F, Hak E, van Grootheest K. Härmark L, et al. Vaccine. 2011 Feb 24;29(10):1941-7. doi: 10.1016/j.vaccine.2010.12.123. Epub 2011 Jan 12. Vaccine. 2011. PMID: 21236235 Free article.

3

Longitudinal monitoring of the safety of drugs by using a web-based system: the case of pregabalin.

Härmark L, Puijenbroek E, Grootheest K. Härmark L, et al. Pharmacoepidemiol Drug Saf. 2011 Jun;20(6):591-7. doi: 10.1002/pds.2135. Pharmacoepidemiol Drug Saf. 2011. PMID: 21538671

4

Web-based intensive monitoring: from passive to active drug surveillance.

Härmark L, van Grootheest K. Härmark L, et al. Expert Opin Drug Saf. 2012 Jan;11(1):45-51. doi: 10.1517/14740338.2012.629184. Epub 2011 Oct 18. Expert Opin Drug Saf. 2012. PMID: 22007719 Review.

5

Experiences with adverse drug reaction reporting by patients: an 11-country survey.

van Hunsel F, Härmark L, Pal S, Olsson S, van Grootheest K. van Hunsel F, et al. Among authors: harmark l. Drug Saf. 2012 Jan 1;35(1):45-60. doi: 10.2165/11594320-000000000-00000. Drug Saf. 2012. PMID: 22149419 Review.

6

Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres.

Harrison-Woolrych M, Härmark L, Tan M, Maggo S, van Grootheest K. Harrison-Woolrych M, et al. Among authors: harmark l. Eur J Clin Pharmacol. 2012 Jul;68(7):1065-72. doi: 10.1007/s00228-012-1220-y. Epub 2012 Feb 8. Eur J Clin Pharmacol. 2012. PMID: 22315148

7

Intensive monitoring of duloxetine: results of a web-based intensive monitoring study.

Härmark L, van Puijenbroek E, van Grootheest K. Härmark L, et al. Eur J Clin Pharmacol. 2013 Feb;69(2):209-15. doi: 10.1007/s00228-012-1313-7. Epub 2012 Jun 12. Eur J Clin Pharmacol. 2013. PMID: 22688722 Free PMC article. Clinical Trial.

8

Patients' motives for participating in active post-marketing surveillance.

Härmark L, Lie-Kwie M, Berm L, de Gier H, van Grootheest K. Härmark L, et al. Pharmacoepidemiol Drug Saf. 2013 Jan;22(1):70-6. doi: 10.1002/pds.3327. Epub 2012 Jul 27. Pharmacoepidemiol Drug Saf. 2013. PMID: 22836782

9

Representativeness of diabetes patients participating in a web-based adverse drug reaction monitoring system.

Härmark L, Alberts S, van Puijenbroek E, Denig P, van Grootheest K. Härmark L, et al. Pharmacoepidemiol Drug Saf. 2013 Mar;22(3):250-5. doi: 10.1002/pds.3341. Epub 2012 Aug 30. Pharmacoepidemiol Drug Saf. 2013. PMID: 22933342

10

Non-response in a pharmacy and patient-based intensive monitoring system: a quantitative study on non-response bias and reasons for non-response.

Härmark LV, Huls HJ, de Gier JJ, van Grootheest AC. Härmark LV, et al. Int J Pharm Pract. 2014 Apr;22(2):159-62. doi: 10.1111/ijpp.12038. Epub 2013 May 20. Int J Pharm Pract. 2014. PMID: 23683068

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters